LINDA FULLER: Open Payments
NPI 1609045343 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,463 in 73 payments from 26 companies in 2025. Trend: 2023 $1,143 · 2024 $1,565 · 2025 $1,463
Food & beverage: $1,463
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $170 |
| Lilly USA, LLC | 8 | $167 |
| Novo Nordisk Inc | 7 | $137 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| ABBVIE INC. | 4 | $76 |
| Exact Sciences Corporation | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| Dexcom, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
Products named: MOUNJARO, TRELEGY ELLIPTA, REXULTI, Dexcom G6 Transmitter, CAPLYTA, ELIQUIS, VOQUEZNA, FREESTYLE LIBRE 3.
Industry payments across NY — which companies pay providers there.
